YUNMIN CHEN: Open Payments
NPI 1043823347 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 19 payments from 10 companies in 2025. Trend: 2023 $2,189 · 2024 $1,500 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $195 |
| Novo Nordisk Inc | 3 | $185 |
| Exact Sciences Corporation | 3 | $63 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $14 |
Products named: Wegovy, QULIPTA, The Cologuard Plus Collection Kit, MOUNJARO, Rybelsus, AIRSUPRA, VERQUVO, BOTOX.
Industry payments across FL — which companies pay providers there.
